公开(公告)号：US11337947B2

公开(公告)日：2022-05-24

申请号：US16494661

申请日：2018-02-23

Applicant: NOSTER INC.

Inventor： Hidenori Matsui ,  Marina Kawaguchi

IPC: A61K31/201 ,  C07K14/205 ,  A61K38/00

Abstract: The present invention provides a composition for inhibiting proliferation of a bacterium provided with a menaquinone synthesis route via futalosine or a futalosine derivative, which contains a fatty acid having 18 carbon atoms and a hydroxyl group at the 10-position as an active ingredient. Furthermore, the present invention provides a composition for preventing or treating a disease caused by a bacterium provided with a menaquinone synthesis route via futalosine or a futalosine derivative.

公开(公告)号：US20230285343A1

公开(公告)日：2023-09-14

申请号：US17732057

申请日：2022-04-28

Applicant: NOSTER INC.

Inventor： Hidenori Matsui ,  Marina Kawaguchi

IPC: A61K31/201 ,  C07K14/205

CPC classification number: A61K31/201 ,  C07K14/205 ,  A61K38/00

Abstract: The present invention provides a composition for inhibiting proliferation of a bacterium provided with a menaquinone synthesis route via futalosine or a futalosine derivative, which contains a fatty acid having 18 carbon atoms and a hydroxyl group at the 10-position as an active ingredient. Furthermore, the present invention provides a composition for preventing or treating a disease caused by a bacterium provided with a menaquinone synthesis route via futalosine or a futalosine derivative.